| __timestamp | Johnson & Johnson | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21954000000 | 10811000 |
| Thursday, January 1, 2015 | 21203000000 | 33001000 |
| Friday, January 1, 2016 | 19945000000 | 64936000 |
| Sunday, January 1, 2017 | 21420000000 | 99909000 |
| Monday, January 1, 2018 | 22540000000 | 127724000 |
| Tuesday, January 1, 2019 | 22178000000 | 161524000 |
| Wednesday, January 1, 2020 | 22084000000 | 182933000 |
| Friday, January 1, 2021 | 20118000000 | 219982000 |
| Saturday, January 1, 2022 | 19046000000 | 278139000 |
| Sunday, January 1, 2023 | 20112000000 | 309799000 |
| Monday, January 1, 2024 | 21969000000 |
Cracking the code
In the ever-evolving landscape of the pharmaceutical industry, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Johnson & Johnson and Ultragenyx Pharmaceutical Inc. have showcased contrasting trajectories in their SG&A spending.
From 2014 to 2023, Johnson & Johnson's SG&A expenses have seen a modest decline of approximately 9%, reflecting a strategic focus on cost optimization. In contrast, Ultragenyx Pharmaceutical Inc. has experienced a staggering increase of over 2,700% in the same period, indicative of its aggressive growth strategy and expansion efforts.
This divergence highlights the different stages and strategies of these companies. While Johnson & Johnson leverages its established market presence to streamline operations, Ultragenyx is investing heavily in its future, aiming to carve out a significant niche in the competitive pharmaceutical sector.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and AstraZeneca PLC
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Selling, General, and Administrative Costs: Johnson & Johnson vs Verona Pharma plc
Johnson & Johnson or Merus N.V.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Alkermes plc or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Ultragenyx Pharmaceutical Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.